Assay Development

XING Diagnostics has extensive experience in designing disruptive technologies for the accurate screening and diagnosis of infectious diseases and cancers. XING has extremely high standards of product development and proprietary bioinformatics which are supported by state-of-the-art technology, laboratory management systems, and facilities. The company has an operating pathology laboratory which is accredited by NATA under ISO15189 with RCPA endorsement. XING’s analytical capabilities are supported by the latest equipment to ensure comprehensive analysis for use in point-of-care diagnostics and cancer oncology.

Patents

XING’s nanotechnologies are protected by global patents and exclusive licenses.

Nanoyeast

US20150377880A1

Nanoshearing

US10156546B2

Single Drop Genomics

US10465236B2

Rapid DNA/RNA Extraction

Australian Patent Application No. 2018308720

Scroll to Top